10-K: UHT Reports 2025 Net Income Decline Amidst Healthcare Headwinds

Sentiment:

Annual Report


Universal Health Realty Income Trust reported a decrease in net income and Funds From Operations for 2025, despite a slight revenue increase, as it navigates a complex healthcare real estate landscape.

Capital raiseFiled a shelf registration statement on Form S-3 in April 2024, allowing the company to offer up to $100 million of securities.Relies on borrowings from its $425 million revolving credit agreement, which had $68.8 million of available borrowing capacity as of December 31, 2025.May obtain additional funds through borrowings under or refinancing of existing third-party debt, issuance of other long-term debt, and/or issuance of equity.
Worse than expectedNet income decreased by $1.6 million (8.3%) in 2025 compared to 2024.Funds From Operations (FFO) decreased by $184,000 (0.4%) in 2025 compared to 2024.FFO per diluted share decreased from $3.46 in 2024 to $3.44 in 2025.The company's stock price performance significantly lagged both the S&P 500 and its peer group over the past five years.

Summary

  • Universal Health Realty Income Trust (UHT) is a real estate investment trust (REIT) focused on healthcare and human service facilities, with 77 investments across 21 states as of February 25, 2026.
  • The portfolio includes six hospitals, four free-standing emergency departments (FEDs), 61 medical/office buildings (MOBs), four childcare centers, one vacant specialty facility, and vacant land.
  • Net income for the year ended December 31, 2025, decreased to $17.6 million, down from $19.2 million in 2024.
  • Revenues saw a modest increase of 0.2% to $99.2 million in 2025, compared to $99.0 million in 2024.
  • Funds From Operations (FFO) decreased slightly to $47.7 million in 2025 from $47.9 million in 2024, with FFO per diluted share at $3.44 in 2025 versus $3.46 in 2024.
  • Lease payments from Universal Health Services, Inc. (UHS) and its related tenants constituted approximately 40% of consolidated revenues for the five years ended December 31, 2025.
  • Advisory fees paid to UHS amounted to $5.6 million in 2025, an increase from $5.5 million in 2024.
  • The company's Credit Agreement was amended on September 30, 2024, extending its maturity to September 30, 2028, and increasing borrowing capacity to $425 million; $68.8 million was available as of December 31, 2025.
  • New construction projects include Palm Beach Gardens Medical Plaza I (80,000 sq ft MOB) with an estimated cost of $34 million, commenced in February 2026 and expected completion in Q4 2026.
  • The company adopted a Clawback Policy, effective October 2, 2023, for the recovery of incentive compensation in the event of an accounting restatement.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a challenging period marked by declining profitability and FFO, coupled with significant external risks from healthcare policy changes and inflation, despite some positive operational metrics and new development.

Positives

  • Revenues increased slightly by $179,000, or 0.2%, to $99.2 million in 2025.
  • Bonus rental revenue increased by $362,000 in 2025.
  • Weighted-average rental rates on renewed medical office building (MOB) leases increased by approximately 3% in 2025.
  • The Advisory Agreement with UHS of Delaware, Inc. was renewed for 2026 with the same terms as prior years, indicating continued stability in this key relationship.
  • The company was in compliance with all covenants in its Credit Agreement as of December 31, 2025, demonstrating sound financial management (e.g., Total leverage 43.6% vs. <=60% limit, Fixed charge coverage 3.3x vs. >=1.50x).
  • New development projects, such as Palm Beach Gardens Medical Plaza I ($34 million estimated cost) and Sierra Medical Plaza I ($35 million aggregate cost), indicate ongoing portfolio growth and investment.

Negatives

  • Net income decreased by $1.6 million to $17.6 million in 2025 from $19.2 million in 2024, primarily due to a $1.0 million net decrease in income from various properties and a $610,000 property tax reduction recorded in 2024 that related to prior periods.
  • Funds From Operations (FFO) decreased by $184,000 to $47.7 million in 2025 from $47.9 million in 2024.
  • A nonrecurring depreciation expense of approximately $900,000 was recorded during the third quarter of 2025.
  • An MOB in Amarillo, Texas, was vacated during the fourth quarter of 2025 upon lease expirations, resulting in a $545,000 reduction in revenue.
  • Interest rate swap income decreased by $2.7 million in 2025 compared to 2024, due to expiring swaps and new swaps with higher fixed rates.
  • The company's stock price performance significantly underperformed both the S&P 500 Index and its peer group over the five years ended December 2025, with a total cumulative return of $82.76 from a $100 base in December 2020, compared to $196.16 for the S&P 500 and $209.49 for the peer group.
  • The company holds a vacant specialty facility in Evansville, Indiana, and vacant land in Chicago, Illinois, which continue to incur operating expenses without generating revenue.

Risks

  • A substantial portion of revenues (approximately 40%) is dependent on one operator, Universal Health Services, Inc. (UHS); non-renewal of leases or exercise of purchase options by UHS could materially reduce revenues.
  • Increased interest rates have significantly raised borrowing costs, reducing net income, cash flow, and FFO, and unfavorably impacting access to capital markets.
  • The 'One Big Beautiful Bill Act' (July 4, 2025) introduces work and community service requirements for Medicaid eligibility, limits provider fees, and eliminates certain insurance exchange premium tax credits beyond 2025, which is expected to reduce operator revenues and increase uncompensated care.
  • Uncertainty exists regarding the extension of enhanced premium tax credits (H.R.1834 passed by the U.S. House, under Senate review), which expired on December 31, 2025.
  • Continuing inflationary pressures on personnel, supply, and construction costs for tenants may impact their ability and willingness to make rental payments.
  • Deterioration in general economic conditions, including higher unemployment and uninsured rates, could lead to decreased patient volumes for operators and reduced occupancy rates at medical office buildings.
  • Increased competition and capacity in certain real estate markets, along with potential decreases in occupancy and rental rates, may adversely impact operating results and property values.
  • The relationship with UHS, which serves as the company's Advisor and whose employees are the company's officers, may create conflicts of interest.
  • Holding non-controlling equity ownership interests in joint ventures exposes the company to potential losses and may not always be beneficial.
  • Bankruptcy, default, insolvency, or financial deterioration of tenants could significantly delay rent collection or necessitate finding new operators.
  • Real estate ownership entails risks such as illiquidity, market fluctuations, maintenance costs, environmental hazards, catastrophic weather events, and the effects of climate change.
  • Failure to maintain REIT status would subject the company to federal income tax at regular corporate rates, significantly reducing cash flow for distributions.
  • Dividends paid by REITs generally do not qualify for reduced tax rates, potentially making investment in REITs less attractive to individual investors compared to other corporations.
  • Compliance with REIT requirements may force the company to forgo otherwise attractive investment opportunities.
  • Significant potential liabilities and rising insurance costs for operators could affect their ability to meet obligations to the company.
  • Dependence on key management personnel means the departure of senior executives or local hospital management could harm the business.
  • Increased competition in the healthcare industry and consolidation at the operator or REIT level could reduce profitability.
  • Substantial renovation costs may be required to adapt vacant healthcare properties for other operators or tenants.
  • Cybersecurity incidents, including ransomware attacks, could lead to HIPAA violations, data breaches, significant costs, penalties, litigation, and reputational damage.
  • Changes to U.S. trade policies, such as new tariffs, could adversely impact tenants' businesses and financial results due to increased costs.
  • Required regulatory approvals can delay or prohibit transfers of healthcare facilities, impacting the ability to replace tenants or operators.
  • Anti-takeover provisions in the declaration of trust and bylaws, and in leases with UHS (e.g., UHS's right to purchase leased facilities upon a change of control), may delay, defer, or prevent a change in control.

Future Outlook

The company cannot predict whether leases with Universal Health Services, Inc. (UHS) or other tenants will be renewed at current or fair market value rates, which could necessitate finding new operators or entering less favorable lease terms. If UHS exercises its options to purchase leased facilities, future revenues could decrease if a favorable rate of return on sale proceeds is not achieved. The impact of recent and future healthcare policy changes, including the 'One Big Beautiful Bill Act' and uncertainties surrounding enhanced premium tax credits, is expected to reduce operator revenues and increase uncompensated care, unfavorably impacting results. The company also faces uncertainty regarding the persistence and acceleration of inflationary pressures on tenant expenses and construction costs, which may outpace reimbursement rate increases. The company expects to finance future capital expenditures, acquisitions, and dividends through internally generated funds, borrowings under its credit agreement, and potential debt or equity issuances, believing it has sufficient capital resources for the next twelve months, though access to financing on acceptable terms is not assured.

Management Comments

  • We believe that the quality and depth of the management and advisory services provided to us by our Advisor and UHS could not be replicated by contracting with unrelated third parties or by being self-advised without considerable cost increases.
  • We believe that these relationships have been beneficial to us in the past, but we cannot guarantee that they will not become detrimental to us in the future.
  • Management cannot predict whether the leases with wholly-owned subsidiaries of UHS, which have renewal options at existing lease rates or fair market value lease rates, or any of our other leases, will be renewed at the end of their lease term.
  • If the leases are not renewed at their current rates or the fair market value lease rates, we would be required to find other operators for those facilities and/or enter into leases on terms potentially less favorable to us than the current leases.
  • If subsidiaries of UHS exercise their options to purchase the respective leased hospital or FED facilities upon expiration of the lease terms, our future revenues could decrease if we were unable to earn a favorable rate of return on the sale proceeds received, as compared to the rental revenue currently earned pursuant to these leases.
  • We believe that our operating cash flows, cash and cash equivalents, available borrowing capacity under our Credit Agreement and access to the capital markets provide us with sufficient capital resources to fund our operating, investing and financing requirements for the next twelve months, including providing sufficient capital to allow us to make distributions necessary to enable us to continue to qualify as a REIT under Sections 856 to 860 of the Internal Revenue Code of 1986.

Industry Context

StockSavvy.ai notes that the healthcare real estate sector faces ongoing challenges from evolving government reimbursement policies (Medicare, Medicaid, ACA changes), which directly impact tenant profitability and, consequently, REIT rental income. The 'One Big Beautiful Bill Act' and the expiration of enhanced premium tax credits signal a tightening regulatory and funding environment, potentially increasing uncompensated care for operators like UHS. Inflationary pressures on labor and construction costs are a sector-wide concern, affecting development project returns and operational expenses for tenants. The continued reliance on a single major tenant (UHS) for a significant portion of revenue, while providing stability, also concentrates risk, a common theme in specialized REITs.

Comparison to Industry Standards

  • UHT's total cumulative return on investment of $82.76 (from a $100 base in December 2020) significantly underperformed the S&P 500 Index, which returned $196.16 over the same period.
  • UHT also significantly underperformed its peer group, which includes Healthcare Realty Trust, Inc., Healthpeak Properties, Inc., LTC Properties, Inc., National Health Investors, Inc., Omega Healthcare Investors, Inc., and Welltower, Inc., with the peer group returning $209.49 over the same five-year period.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Vice President, Acquisitions and DevelopmentNAKarla J. Peterson2022Commencement of employment with UHS.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Policy AdoptionAdopted a Clawback Policy for the recovery of incentive compensation in the event of an accounting restatement, designed to comply with Section 10D of the Exchange Act and NYSE Rule 10D-1.October 2, 2023Enhances corporate accountability and aligns executive incentives with accurate financial reporting, potentially reducing financial risk from restatements.
Advisory Agreement RenewalThe Advisory Agreement with UHS of Delaware, Inc. was renewed for 2026 with the same terms as the prior three years, subject to satisfactory performance determination by Independent Trustees.December 31, 2026 (renewal through)Ensures continuity of management and administrative services from a related party, but also maintains the potential for conflicts of interest which are mitigated by Independent Trustee approval for UHS transactions.
Cybersecurity OversightThe Audit Committee of the Board of Trustees is responsible for the oversight of risks from cybersecurity threats, receiving annual updates on the evolving threat landscape, significant risks, incidents, and control maturity.OngoingStrengthens governance around critical IT infrastructure and data protection, addressing a growing risk area for the healthcare industry.

Legal Proceedings

  • The Trust itself has no legal proceedings mentioned in Item 3.
  • Universal Health Services, Inc. (UHS) and its subsidiaries are subject to pending legal actions, governmental investigations, and regulatory actions, which could have a material adverse effect on UHS's business, financial condition, results of operations, and/or cash flows, and in turn, on the Trust due to its significant reliance on UHS.

Related Party Transactions

  • UHS of Delaware, Inc., a wholly-owned subsidiary of UHS, serves as the Trust's Advisor under an annually renewable Advisory Agreement, renewed for 2026 with the same terms as 2025, 2024, and 2023.
  • All officers of the Trust are employees of UHS through its wholly-owned subsidiary, UHS of Delaware, Inc.
  • Lease payments from UHS-related tenants comprised approximately 40% of the Trust's consolidated revenues for the five years ended December 31, 2025.
  • Advisory fees paid to UHS amounted to $5.6 million in 2025, $5.5 million in 2024, and $5.3 million in 2023.
  • UHS owned 5.7% of the Trust's outstanding shares of beneficial interest as of December 31, 2025 and 2024.
  • The Trust has financing receivables from UHS totaling $82.1 million as of December 31, 2025, stemming from a failed sale-leaseback transaction involving Aiken Regional Medical Center and Canyon Creek Behavioral Health.
  • UHS holds options to renew leases and purchase leased hospital and free-standing emergency department facilities at appraised fair market value.
  • The Trust is the lessee on fourteen ground leases with subsidiaries of UHS for consolidated and unconsolidated investments.
  • A UHS subsidiary was engaged as project manager for the construction of Palm Beach Gardens Medical Plaza I, an MOB with an estimated cost of $34 million.

Stakeholder Impact

  • **Shareholders**: Face potential for reduced dividends due to declining net income and FFO, and risks associated with the significant reliance on UHS. The stock's underperformance relative to market and peers may also impact shareholder value. Anti-takeover provisions could limit opportunities for a control premium.
  • **Tenants (Operators)**: Particularly those in acute care, behavioral health, and FEDs, are significantly impacted by changes in federal and state healthcare programs (Medicare, Medicaid, ACA), inflationary pressures on labor and supply costs, and staffing shortages, which could affect their financial viability and ability to meet lease obligations.
  • **Employees (Trust Officers)**: While employees of UHS, they receive stock-based compensation from the Trust and are subject to the newly adopted Clawback Policy, linking their compensation to accurate financial reporting.
  • **Creditors**: The company's ability to meet its debt obligations is tied to its operating performance and access to capital markets, which are subject to interest rate fluctuations and economic conditions. Strong compliance with debt covenants is positive for creditors.

Next Steps

  • Completion of construction for Palm Beach Gardens Medical Plaza I, expected during the fourth quarter of 2026.
  • Completion and opening of the Alan B. Miller Medical Center, expected during the second quarter of 2026.
  • Continued marketing of the vacant land in Chicago, Illinois, and the vacant specialty facility in Evansville, Indiana, for sale or lease.
  • Ongoing evaluation of new accounting standards (ASU 2025-09 and ASU 2024-03) for their potential impact on financial statements.
  • Future dividend levels will be determined based on projected operating cash flows, capital commitments, and debt repayments.

Key Dates

DateDescription
December 24, 1986Original Advisory Agreement date between Universal Health Realty Income Trust and UHS of Delaware, Inc.
January 1, 2019Effective date of the amended and restated Advisory Agreement.
March 25, 2020Effective date of a $55 million interest rate swap agreement.
December 31, 2021Asset purchase and sale agreement with UHS for Aiken Regional Medical Center and Canyon Creek Behavioral Health.
March 2023Ground lease and master flex-lease agreement commenced for Sierra Medical Plaza I in Reno, Nevada.
December 1, 2023Effective date of a $25 million interest rate swap agreement.
October 2, 2023Effective date of the Clawback Policy.
April 2024Filed a shelf registration statement on Form S-3 to offer up to $100 million of securities.
May 20, 2025Tuscan Professional Building fixed rate mortgage loan fully repaid.
February 24, 2025Effective date of the Insider Trading Policy.
July 4, 2025Legislation adopted ('One Big Beautiful Bill Act') impacting Medicaid and insurance exchange premium tax credits.
June 2025U.S. Supreme Court's Kennedy v. Braidwood Management decision on ACA HIV preventive care coverage.
September 16, 2024Expiration date of two interest rate swap agreements totaling $85 million notional amount.
September 30, 2024Second amendment to the Credit Agreement, extending maturity to September 30, 2028.
October 2, 2024Effective date of a new $85 million interest rate swap agreement.
October 2024UHS subsidiaries exercised 5-year renewal options on two FEDs in Weslaco and Mission, Texas, covering February 1, 2025, through January 31, 2030.
October 2025Entered into a ground lease with a UHS subsidiary to develop Palm Beach Gardens Medical Plaza I.
December 10, 2025Board of Trustees authorized the renewal of the Advisory Agreement for 2026.
December 31, 2025Fiscal year ended for the annual report.
January 8, 2026U.S. House of Representatives passed H.R.1834 to extend enhanced premium tax credits.
January 31, 2026Number of shares of beneficial interest outstanding reported.
February 2026Construction commenced on Palm Beach Gardens Medical Plaza I.
February 25, 2026Date of filing of the 10-K annual report and audit report.
Q2 2026Expected completion and opening of the Alan B. Miller Medical Center.
December 2026Lease end for McAllen Medical Center and Wellington Regional Medical Center.
Q4 2026Expected completion of Palm Beach Gardens Medical Plaza I.
March 25, 2027Maturity date of a $55 million interest rate swap agreement.
December 1, 2027Maturity date of a $25 million interest rate swap agreement.
September 30, 2028Maturity date of the Credit Agreement and an $85 million interest rate swap agreement.
January 2030Maturity date of Phoenix Childrens East Valley Care Center fixed rate mortgage loan.
August 31, 2035Expiration of the master lease for McAllen Doctor's Center.
March 2, 2098Expiration of the ground lease for Sierra Medical Plaza I.

Recommendation

hold

The company operates in a stable, essential sector (healthcare real estate) and maintains strong compliance with debt covenants. However, declining net income and FFO, significant reliance on a single tenant (UHS) with potential conflicts of interest, and exposure to adverse healthcare policy changes and inflationary pressures present notable headwinds. The stock's underperformance relative to peers and the broader market suggests limited upside potential in the near term, but the long-term nature of its assets and lease structures provide a degree of stability. Investors should hold while monitoring the impact of healthcare reforms, inflation, and the company's ability to diversify its tenant base and achieve favorable returns on new developments.

Keywords

REIT, Healthcare Real Estate, Medical Office Buildings, Hospitals, Behavioral Health, Free-standing Emergency Departments, Universal Health Realty Income Trust, UHT, SEC Filing, 10-K, Lease Revenue, Real Estate Investment Trust, Property Management, Healthcare Facilities

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.